These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical guidelines: Dosing and switching strategies for long-acting risperidone. Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418 [No Abstract] [Full Text] [Related]
4. Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. Kim SW; Kim KM; Kim JM; Shin IS; Shin HY; Yang SJ; Yoon JS Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):543-5. PubMed ID: 17110011 [TBL] [Abstract][Full Text] [Related]
5. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria. Gómez-Perretta C Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229 [No Abstract] [Full Text] [Related]
6. Benefit of extending the dosing interval of long-acting antipsychotic injections in elderly schizophrenics with cognitive dysfunction. Suzuki H; Hibino H; Inoue Y; Mikami A; Matsumoto H; Mikami K Psychogeriatrics; 2017 Nov; 17(6):522-523. PubMed ID: 28321952 [No Abstract] [Full Text] [Related]
12. Acute dystonic reaction with risperidone. Takhar J; Manchanda R Can J Psychiatry; 1996 Feb; 41(1):61-2. PubMed ID: 8919428 [No Abstract] [Full Text] [Related]
13. Risperidone in schizophrenia: is there a role for therapeutic drug monitoring? Seto K; Dumontet J; Ensom MH Ther Drug Monit; 2011 Jun; 33(3):275-83. PubMed ID: 21436762 [TBL] [Abstract][Full Text] [Related]
14. Combination risperidone and quetiapine therapy in refractory schizophrenia. Chue P; Welch R; Snaterse M Can J Psychiatry; 2001 Feb; 46(1):86-7. PubMed ID: 11221496 [No Abstract] [Full Text] [Related]
15. Concurrent administration of donepezil HCl and risperidone in patients with schizophrenia: assessment of pharmacokinetic changes and safety following multiple oral doses. Reyes JF; Preskorn SH; Khan A; Kumar D; Cullen EI; Perdomo CA; Pratt RD Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):50-7. PubMed ID: 15496223 [TBL] [Abstract][Full Text] [Related]
16. Risperidone vs. placebo for schizophrenia. Kripke C Am Fam Physician; 2010 May; 81(9):1096. PubMed ID: 20433125 [No Abstract] [Full Text] [Related]
17. Chronic administration of risperidone in a rat model of schizophrenia: a behavioural, morphological and molecular study. Castellano O; Arji M; Sancho C; Carro J; Riolobos AS; Molina V; Gómez-Nieto R; de Anchieta de Castro E Horta J; Herrero-Turrión MJ; López DE Behav Brain Res; 2013 Apr; 242():178-90. PubMed ID: 23291154 [TBL] [Abstract][Full Text] [Related]
18. A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part I. de Leon J; Sandson NB; Cozza KL Psychosomatics; 2008; 49(3):258-70. PubMed ID: 18448784 [TBL] [Abstract][Full Text] [Related]
19. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720 [TBL] [Abstract][Full Text] [Related]
20. Seizure during risperidone treatment in an elderly woman treated with concomitant medications. Lane HY; Chang WH; Chou JC J Clin Psychiatry; 1998 Feb; 59(2):81-2. PubMed ID: 9501890 [No Abstract] [Full Text] [Related] [Next] [New Search]